137 related articles for article (PubMed ID: 17352215)
1. Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features.
Takagi A; Watanabe M; Ishii Y; Morita J; Hirokawa Y; Matsuzaki T; Shiraishi T
Anticancer Res; 2007; 27(1A):45-53. PubMed ID: 17352215
[TBL] [Abstract][Full Text] [Related]
2. Growth and characterization of LNCaP prostate cancer cell spheroids.
Ballangrud AM; Yang WH; Dnistrian A; Lampen NM; Sgouros G
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3171s-3176s. PubMed ID: 10541360
[TBL] [Abstract][Full Text] [Related]
3. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
Erlichman C; Vidgen D
Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
6. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
7. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
8. [Biological behavior of prostate cancer cells in 3D culture systems].
Watanabe M; Takagi A
Yakugaku Zasshi; 2008 Jan; 128(1):37-44. PubMed ID: 18176054
[TBL] [Abstract][Full Text] [Related]
9. Human bladder carcinoma cells with an unusual pattern of in vitro growth: transition from nonproliferative spheroids to active monolayer growth upon interaction with tumor-derived fibroblasts.
Chuang CK; Liao SK
Anticancer Res; 2000; 20(2A):749-60. PubMed ID: 10810350
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids.
Enmon R; Yang WH; Ballangrud AM; Solit DB; Heller G; Rosen N; Scher HI; Sgouros G
Cancer Res; 2003 Dec; 63(23):8393-9. PubMed ID: 14679001
[TBL] [Abstract][Full Text] [Related]
11. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
Mitrofanova E; Hagan C; Qi J; Seregina T; Link C
Anticancer Res; 2003; 23(3B):2397-404. PubMed ID: 12894520
[TBL] [Abstract][Full Text] [Related]
12. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.
Schreiber-Brynzak E; Klapproth E; Unger C; Lichtscheidl-Schultz I; Göschl S; Schweighofer S; Trondl R; Dolznig H; Jakupec MA; Keppler BK
Invest New Drugs; 2015 Aug; 33(4):835-47. PubMed ID: 26091914
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
17. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of cisplatin and cisdiammine-1,1-cyclobutane dicarboxylate in MGH-U1 cells grown as monolayers, spheroids, and xenografts.
Erlichman C; Vidgen D; Wu A
J Natl Cancer Inst; 1985 Sep; 75(3):499-505. PubMed ID: 3897683
[TBL] [Abstract][Full Text] [Related]
19. Spatial composition of prostate cancer spheroids in mixed and static cultures.
Song H; David O; Clejan S; Giordano CL; Pappas-Lebeau H; Xu L; O'Connor KC
Tissue Eng; 2004; 10(7-8):1266-76. PubMed ID: 15363181
[TBL] [Abstract][Full Text] [Related]
20. The role of heat shock protein 70 in the thermoresistance of prostate cancer cell line spheroids.
Khoei S; Goliaei B; Neshasteh-Riz A; Deizadji A
FEBS Lett; 2004 Mar; 561(1-3):144-8. PubMed ID: 15013766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]